These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 25465748)

  • 21. Healthcare utilization and costs of patients with rosacea in an insured population.
    Romanowicz M; Stephenson JJ; Del Rosso JQ; Lenhart G
    J Drugs Dermatol; 2008 Jan; 7(1):41-9. PubMed ID: 18246697
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship of in-hospital medication modifications of elderly patients to postdischarge medications, adherence, and mortality.
    Mansur N; Weiss A; Beloosesky Y
    Ann Pharmacother; 2008 Jun; 42(6):783-9. PubMed ID: 18445704
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Costs of illness and care in Parkinson's disease: an evaluation in six countries.
    von Campenhausen S; Winter Y; Rodrigues e Silva A; Sampaio C; Ruzicka E; Barone P; Poewe W; Guekht A; Mateus C; Pfeiffer KP; Berger K; Skoupa J; Bötzel K; Geiger-Gritsch S; Siebert U; Balzer-Geldsetzer M; Oertel WH; Dodel R; Reese JP
    Eur Neuropsychopharmacol; 2011 Feb; 21(2):180-91. PubMed ID: 20888737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Medication phobia: a new cause of drug noncompliance in Parkinson disease.
    Schlesinger I; Rabinowitz D
    Clin Neuropharmacol; 2011; 34(6):220-3. PubMed ID: 22027928
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medication adherence and healthcare costs among patients with diabetic peripheral neuropathic pain initiating duloxetine versus pregabalin.
    Zhao Y; Sun P; Watson P
    Curr Med Res Opin; 2011 Apr; 27(4):785-92. PubMed ID: 21303196
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Medicaid beneficiaries with congestive heart failure: association of medication adherence with healthcare use and costs.
    Esposito D; Bagchi AD; Verdier JM; Bencio DS; Kim MS
    Am J Manag Care; 2009 Jul; 15(7):437-45. PubMed ID: 19589011
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inflammatory bowel disease: healthcare costs for patients who are adherent or non-adherent with infliximab therapy.
    Wan GJ; Kozma CM; Slaton TL; Olson WH; Feagan BG
    J Med Econ; 2014 Jun; 17(6):384-93. PubMed ID: 24673303
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Medication adherence in patients with Parkinson's disease.
    Malek N; Grosset DG
    CNS Drugs; 2015 Jan; 29(1):47-53. PubMed ID: 25503824
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Parkinson's disease patients first treated at age 75 years or older: a comparative study.
    Peretz C; Chillag-Talmor O; Linn S; Gurevich T; El-Ad B; Silverman B; Friedman N; Giladi N
    Parkinsonism Relat Disord; 2014 Jan; 20(1):69-74. PubMed ID: 24183677
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Costs of Parkinson's disease and antiparkinsonian pharmacotherapy: an Italian cohort study.
    Winter Y; von Campenhausen S; Reese JP; Balzer-Geldsetzer M; Longo K; Spiga G; Boetzel K; Eggert K; Oertel WH; Dodel R; Barone P
    Neurodegener Dis; 2010; 7(6):365-72. PubMed ID: 20523028
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Healthcare utilization in patients with Parkinson's disease: a population-based analysis.
    Hobson DE; Lix LM; Azimaee M; Leslie WD; Burchill C; Hobson S
    Parkinsonism Relat Disord; 2012 Sep; 18(8):930-5. PubMed ID: 22621819
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Direct costs of managing Parkinson's disease in India: concerns in a developing country.
    Ragothaman M; Govindappa ST; Rattihalli R; Subbakrishna DK; Muthane UB
    Mov Disord; 2006 Oct; 21(10):1755-8. PubMed ID: 16874759
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prediction model of Parkinson's disease based on antiparkinsonian drug claims.
    Moisan F; Gourlet V; Mazurie JL; Dupupet JL; Houssinot J; Goldberg M; Imbernon E; Tzourio C; Elbaz A
    Am J Epidemiol; 2011 Aug; 174(3):354-63. PubMed ID: 21606234
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prescribing pattern of anti-Parkinson drugs in Southern Italy: cross-sectional analysis in the years 2003-2005.
    Trifirò G; Savica R; Morgante L; Vanacore N; Tari M; Moretti S; Galdo M; Spina E; Caputi AP; Arcoraci V
    Parkinsonism Relat Disord; 2008; 14(5):420-5. PubMed ID: 18316232
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trends in resource utilization for Parkinson's disease in Germany.
    Winter Y; Balzer-Geldsetzer M; von Campenhausen S; Spottke A; Eggert K; Oertel WH; Dodel R
    J Neurol Sci; 2010 Jul; 294(1-2):18-22. PubMed ID: 20493500
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Self-reported adherence versus pill count in Parkinson's disease: the NET-PD experience.
    Elm JJ; Kamp C; Tilley BC; Guimaraes P; Fraser D; Deppen P; Brocht A; Weaver C; Bennett S;
    Mov Disord; 2007 Apr; 22(6):822-7. PubMed ID: 17357141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug costs for patients with Parkinson's disease in two different European countries.
    Vossius C; Gjerstad M; Baas H; Larsen JP
    Acta Neurol Scand; 2006 Apr; 113(4):228-32. PubMed ID: 16542161
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relative effectiveness of budesonide/formoterol and fluticasone propionate/salmeterol in a 1-year, population-based, matched cohort study of patients with chronic obstructive pulmonary disease (COPD): Effect on COPD-related exacerbations, emergency department visits and hospitalizations, medication utilization, and treatment adherence.
    Blais L; Forget A; Ramachandran S
    Clin Ther; 2010 Jul; 32(7):1320-8. PubMed ID: 20678680
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Challenges and strategies of medication adherence in Parkinson's disease: A qualitative study.
    Shin JY; Habermann B; Pretzer-Aboff I
    Geriatr Nurs; 2015; 36(3):192-6. PubMed ID: 25728485
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Retrospective claims database analysis to determine relationship between renin-angiotensin system agents, rehospitalization, and health care costs in patients with heart failure or myocardial infarction.
    Sun SX; Ye X; Lee KY; Dupclay L; Plauschinat C
    Clin Ther; 2008; 30 Pt 2():2217-27. PubMed ID: 19281916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.